CARDIOVASCULAR SYSTEMS INC (CSII)

US1416191062 - Common Stock

20  +0.03 (+0.15%)

After market: 20 0 (0%)

Fundamental Rating

3

Taking everything into account, CSII scores 3 out of 10 in our fundamental rating. CSII was compared to 196 industry peers in the Health Care Equipment & Supplies industry. CSII scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CSII is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

CSII had negative earnings in the past year.
In the past year CSII has reported a negative cash flow from operations.
CSII had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CSII reported negative operating cash flow in multiple years.

1.2 Ratios

The profitability ratios for CSII are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CSII has a better Gross Margin (72.39%) than 82.46% of its industry peers.
In the last couple of years the Gross Margin of CSII has declined.
The Profit Margin and Operating Margin are not available for CSII so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.96%

5

2. Health

2.1 Basic Checks

CSII does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSII has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CSII has been increased compared to 5 years ago.
Compared to 1 year ago, CSII has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.06 indicates that CSII is not in any danger for bankruptcy at the moment.
CSII's Altman-Z score of 6.06 is amongst the best of the industry. CSII outperforms 80.57% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CSII is not too dependend on debt financing.
CSII's Debt to Equity ratio of 0.08 is in line compared to the rest of the industry. CSII outperforms 58.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 6.06
ROIC/WACCN/A
WACC9.65%

2.3 Liquidity

A Current Ratio of 6.04 indicates that CSII has no problem at all paying its short term obligations.
CSII's Current ratio of 6.04 is fine compared to the rest of the industry. CSII outperforms 72.99% of its industry peers.
A Quick Ratio of 4.92 indicates that CSII has no problem at all paying its short term obligations.
CSII's Quick ratio of 4.92 is fine compared to the rest of the industry. CSII outperforms 72.04% of its industry peers.
Industry RankSector Rank
Current Ratio 6.04
Quick Ratio 4.92

4

3. Growth

3.1 Past

The earnings per share for CSII have decreased strongly by -46.97% in the last year.
The Revenue has decreased by -4.73% in the past year.
CSII shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.89% yearly.
EPS 1Y (TTM)-46.97%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q13.04%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-1.61%
Revenue growth 5Y2.89%
Revenue growth Q2Q3.92%

3.2 Future

CSII is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.08% yearly.
CSII is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.69% yearly.
EPS Next Y28.21%
EPS Next 2Y21.47%
EPS Next 3Y19.08%
EPS Next 5YN/A
Revenue Next Year8.64%
Revenue Next 2Y9.57%
Revenue Next 3Y10.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

CSII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CSII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CSII's earnings are expected to grow with 19.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.47%
EPS Next 3Y19.08%

0

5. Dividend

5.1 Amount

No dividends for CSII!.
Industry RankSector Rank
Dividend Yield N/A

CARDIOVASCULAR SYSTEMS INC

NASDAQ:CSII (4/27/2023, 7:22:19 PM)

After market: 20 0 (0%)

20

+0.03 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap839.18M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 72.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.04
Quick Ratio 4.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-46.97%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-1.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y